Nipple Secretion Samples in Detecting Breast Cancer in Patients and Healthy Participants Undergoing Breast Cancer Screening, Breast Diagnostic Studies, or Treatment for Benign Breast Disease

NCT00813878 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 126

Last updated 2017-10-13

No results posted yet for this study

Summary

RATIONALE: Diagnostic procedures that measure biomarker levels in nipple section and blood samples, may help in the early detection of breast cancer.

PURPOSE: This clinical trial is studying nipple secretion samples in detecting breast cancer in patients and healthy participants undergoing breast cancer screening, breast diagnostic studies, or treatment for benign breast disease.

Conditions

Interventions

GENETIC

protein analysis

protein analysis

GENETIC

protein expression analysis

protein expression analysis

GENETIC

proteomic profiling

proteomic profiling

OTHER

diagnostic laboratory biomarker analysis

Performed one time on study

OTHER

immunohistochemistry staining method

Performed one time on study

OTHER

liquid chromatography

Performed on samples collected one time on study

OTHER

mass spectrometry

Performed on samples collected one time on study

PROCEDURE

fine-needle aspiration

Samples collected one time on study at the appointment for fine-needle aspiration where applicable

PROCEDURE

needle biopsy

Samples collected one time on study at the appointment for needle biopsy where applicable

PROCEDURE

radiomammography

Samples collected one time on study at the appointment for radiomammography where applicable

Sponsors & Collaborators

  • National Cancer Institute (NCI)

    collaborator NIH
  • City of Hope Medical Center

    lead OTHER

Principal Investigators

  • John Yim, MD · City of Hope Comprehensive Cancer Center

Eligibility

Min Age
18 Years
Max Age
120 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2001-07-31
Primary Completion
2012-09-30
Completion
2012-09-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00813878 on ClinicalTrials.gov